← Leaderboards
Lisa J Wood
Oregon Health & Science University
$3,498,714
Attributed
$4,866,673
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $958.5K · FY2007–19$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$4,866,673 · 6
By mechanism
R01$3,265,073 · 2
R21$1,601,600 · 4
Top collaborators
- Bruce E. Magun4 shared
- Kim Dupree Jones2 shared
- Janet A. Kneiss2 shared
- Kerri M Winters-Stone2 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Saurabh Suhas Thosar$2,508,434
- Marian Livingston Dale$745,023
- Colleen Marie Casey$64,733
- Kim Dupree Jones$190,575
- Laurie King$1,576,552
Others in their field
Top investigators on “Fatigue”
- Peter J. Snyder · University Of Pennsylvania$32,402,680
- Arie Kapteyn · Rand Corporation$20,740,048
- Michael R Irwin · University Of California San Diego$19,048,945
- Edward G Shaw · Wake Forest University Health Sciences$15,941,725
- Christine A. Miaskowski · University Of California San Francisco$14,953,251
- Natasha Bassam Halasa · Vanderbilt University Medical Center$14,934,787
Research focus
FatigueInflammatoryResponsePainCytokineQuality Of LifeSleep DisturbancesSymptomsProductionPhysical FunctionMolecularMalignant NeoplasmsCancer PatientAnemiaChemotherapyTreatment-Related CancerBehaviorEsthesiaPlayBody CompositionDoseDesire For FoodPreventCancer Care
Grant awards (17)
Neuromuscular Dysfunction Among Fatigued and Non-Fatigued Breast Cancer Survivors$238,507
R21 · FY2019 · AG · contact PI
Neuromuscular Dysfunction Among Fatigued and Non-Fatigued Breast Cancer Survivors$206,445
R21 · FY2018 · AG · contact PI
Targeting IL-1beta as a strategy for symptom control in cancer$385,575
R01 · FY2015 · NR · contact PI
Targeting IL-1beta as a strategy for symptom control in cancer$393,525
R01 · FY2014 · NR · contact PI
Mechanisms of Cancer Treatment Related Symptoms$178,906
R01 · FY2014 · NR · contact PI
Targeting IL-1beta as a strategy for symptom control in cancer$376,830
R01 · FY2013 · NR · contact PI
Mechanisms of Cancer Treatment Related Symptoms$373,062
R01 · FY2013 · NR · contact PI
Influence of Exercise and Adiposity on Biomarkers of Breast Cancer Recurrence$188,912
R21 · FY2013 · CA
Targeting IL-1beta as a strategy for symptom control in cancer$397,500
R01 · FY2012 · NR · contact PI
Mechanisms of Cancer Treatment Related Symptoms$393,525
R01 · FY2012 · NR · contact PI
Influence of Exercise and Adiposity on Biomarkers of Breast Cancer Recurrence$167,475
R21 · FY2012 · CA
Mechanisms of Cancer Treatment Related Symptoms$381,150
R01 · FY2011 · NR · contact PI
Mechanisms of Cancer Treatment Related Symptoms$385,000
R01 · FY2010 · NR · contact PI
The Neuroendocrine and Inflammatory Response to Exercise in Fibromyalgia$207,900
R21 · FY2010 · AR · contact PI
The Neuroendocrine and Inflammatory Response to Exercise in Fibromyalgia$173,250
R21 · FY2009 · AR · contact PI
The Inflammatory Cytokine Response to Radiation Therapy and Fatigue$226,611
R21 · FY2008 · NR · contact PI
The Inflammatory Cytokine Response to Radiation Therapy and Fatigue$192,500
R21 · FY2007 · NR · contact PI